CRO expands oncology, adds functional service provider capabilities, strengthens global reach, and accelerates technology to enhance customer value RESEARCH TRIANGLECRO expands oncology, adds functional service provider capabilities, strengthens global reach, and accelerates technology to enhance customer value RESEARCH TRIANGLE

Worldwide Clinical Trials Completes Acquisition of Catalyst Clinical Research

2026/02/16 21:15
Okuma süresi: 4 dk

CRO expands oncology, adds functional service provider capabilities, strengthens global reach, and accelerates technology to enhance customer value

RESEARCH TRIANGLE PARK, N.C. & NOTTINGHAM, England–(BUSINESS WIRE)–#CROleader—Worldwide Clinical Trials (“Worldwide” or the “Company”), a global contract research organization (CRO), has completed its acquisition of Catalyst Clinical Research, LCC (“Catalyst”) – a specialized oncology CRO and scalable functional service provider (FSP). This strategic transaction creates a combined organization with highly complementary strengths in oncology, biometrics, and FSP capabilities, substantially enhancing Worldwide’s offerings to biopharma customers globally and expanding its employee base to approximately 4,400 across more than 70 countries.

The addition of Catalyst’s deep expertise in early phase oncology, along with its robust FSP model, significantly augments Worldwide’s scientific depth, operational agility, and therapeutic strengths across neuroscience, oncology, rare disease, and internal medicine. Customers now have access to an expanded suite of services, innovative technology platforms, and a broader global site network – supporting efficient, transparent, and flexible development across the clinical trial lifecycle.

“The acquisition of Catalyst strengthens Worldwide’s capabilities in a very deliberate way, building a stronger, more capable CRO partner for our customers,” said Alistair Macdonald, Chief Executive Officer of Worldwide. “It expands our reach into earlier phase oncology, adds targeted FSP and biometrics capabilities, and accelerates our technology platforms, allowing us to better support customers across the full development lifecycle with greater speed, flexibility, and transparency.”

“The completion of the Catalyst acquisition deepens Worldwide’s oncology offering and global reach,” said Matt Jennings, Executive Chairman of Worldwide and Senior Operating Partner of Kohlberg, the majority owner of the Company. “Catalyst’s expertise, technology, and strong biotech relationships are a natural fit for Worldwide and reinforce our strategy to build a differentiated, technology-enabled CRO.”

“Joining the Worldwide team is an exciting next chapter for Catalyst,” said Nik Morton, former President and CEO of Catalyst, who joins Worldwide as EVP, Chief Strategy & Transformation Officer. “We are energized by the cultural alignment between our teams and share a deep commitment to scientific excellence, operational integrity, and a people-first approach. Together, we are well positioned to deliver even greater value to customers worldwide.”

In addition to Morton, Catalyst’s Chairman of the Board, Nick Dyer, joins Worldwide’s Board of Directors. An integration team has been established, with a comprehensive plan underway to ensure a smooth and effective transition for employees, customers, and partners. The Company will leverage its best strengths and practices to unlock new growth and innovation opportunities for customers.

Worldwide acquired Catalyst for an undisclosed amount.

Worldwide is a portfolio company of Kohlberg. Based in Mount Kisco, N.Y., Kohlberg invests in healthcare and services companies. Prior to the deal closing, Catalyst was a portfolio company of QHP Capital, L.P. (“QHP Capital”). QHP Capital is based in Research Triangle Park, N.C., and invests in life sciences and pharma services companies.

BofA Securities served as exclusive advisor and Smith Anderson served as legal counsel to Catalyst. Greenberg Traurig, LLP served as legal counsel to Worldwide.

About Worldwide Clinical Trials

Worldwide Clinical Trials (Worldwide) is a global CRO serving development-driven biopharmaceutical companies, with more than 4,400 professionals operating across more than 70 countries. The company delivers therapeutically dedicated expertise in neuroscience, oncology, rare disease, and internal medicine, with comprehensive support across every development phase – from early-stage and first-in-human studies through Phase III registration trials.

The company’s flexible service model – spanning full-service trial management to functional service partnerships through Worldwide Flex – is powered by a people-first, partnership-driven outsourcing approach that strengthens collaboration, enhances data transparency, and supports more informed decision making. This provides sponsors with tailored, adaptable solutions that keep pace with the evolving demands of clinical research. Learn more at www.worldwide.com.

Contacts

Media Contact:
Jill Shahravar
Jill.Shahravar@worldwide.com
919-389-9253

Piyasa Fırsatı
Cronos Logosu
Cronos Fiyatı(CRO)
$0.07905
$0.07905$0.07905
+1.06%
USD
Cronos (CRO) Canlı Fiyat Grafiği
Sorumluluk Reddi: Bu sitede yeniden yayınlanan makaleler, halka açık platformlardan alınmıştır ve yalnızca bilgilendirme amaçlıdır. MEXC'nin görüşlerini yansıtmayabilir. Tüm hakları telif sahiplerine aittir. Herhangi bir içeriğin üçüncü taraf haklarını ihlal ettiğini düşünüyorsanız, kaldırılması için lütfen service@support.mexc.com ile iletişime geçin. MEXC, içeriğin doğruluğu, eksiksizliği veya güncelliği konusunda hiçbir garanti vermez ve sağlanan bilgilere dayalı olarak alınan herhangi bir eylemden sorumlu değildir. İçerik, finansal, yasal veya diğer profesyonel tavsiye niteliğinde değildir ve MEXC tarafından bir tavsiye veya onay olarak değerlendirilmemelidir.

Ayrıca Şunları da Beğenebilirsiniz

Facts Vs. Hype: Analyst Examines XRP Supply Shock Theory

Facts Vs. Hype: Analyst Examines XRP Supply Shock Theory

Prominent analyst Cheeky Crypto (203,000 followers on YouTube) set out to verify a fast-spreading claim that XRP’s circulating supply could “vanish overnight,” and his conclusion is more nuanced than the headline suggests: nothing in the ledger disappears, but the amount of XRP that is truly liquid could be far smaller than most dashboards imply—small enough, in his view, to set the stage for an abrupt liquidity squeeze if demand spikes. XRP Supply Shock? The video opens with the host acknowledging his own skepticism—“I woke up to a rumor that XRP supply could vanish overnight. Sounds crazy, right?”—before committing to test the thesis rather than dismiss it. He frames the exercise as an attempt to reconcile a long-standing critique (“XRP’s supply is too large for high prices”) with a rival view taking hold among prominent community voices: that much of the supply counted as “circulating” is effectively unavailable to trade. His first step is a straightforward data check. Pulling public figures, he finds CoinMarketCap showing roughly 59.6 billion XRP as circulating, while XRPScan reports about 64.7 billion. The divergence prompts what becomes the video’s key methodological point: different sources count “circulating” differently. Related Reading: Analyst Sounds Major XRP Warning: Last Chance To Get In As Accumulation Balloons As he explains it, the higher on-ledger number likely includes balances that aggregators exclude or treat as restricted, most notably Ripple’s programmatic escrow. He highlights that Ripple still “holds a chunk of XRP in escrow, about 35.3 billion XRP locked up across multiple wallets, with a nominal schedule of up to 1 billion released per month and unused portions commonly re-escrowed. Those coins exist and are accounted for on-ledger, but “they aren’t actually sitting on exchanges” and are not immediately available to buyers. In his words, “for all intents and purposes, that escrow stash is effectively off of the market.” From there, the analysis moves from headline “circulating supply” to the subtler concept of effective float. Beyond escrow, he argues that large strategic holders—banks, fintechs, or other whales—may sit on material balances without supplying order books. When you strip out escrow and these non-selling stashes, he says, “the effective circulating supply… is actually way smaller than the 59 or even 64 billion figure.” He cites community estimates in the “20 or 30 billion” range for what might be truly liquid at any given moment, while emphasizing that nobody has a precise number. That effective-float framing underpins the crux of his thesis: a potential supply shock if demand accelerates faster than fresh sell-side supply appears. “Price is a dance between supply and demand,” he says; if institutional or sovereign-scale users suddenly need XRP and “the market finds that there isn’t enough XRP readily available,” order books could thin out and prices could “shoot on up, sometimes violently.” His phrase “circulating supply could collapse overnight” is presented not as a claim that tokens are destroyed or removed from the ledger, but as a market-structure scenario in which available inventory to sell dries up quickly because holders won’t part with it. How Could The XRP Supply Shock Happen? On the demand side, he anchors the hypothetical to tokenization. He points to the “very early stages of something huge in finance”—on-chain tokenization of debt, stablecoins, CBDCs and even gold—and argues the XRP Ledger aims to be “the settlement layer” for those assets.He references Ripple CTO David Schwartz’s earlier comments about an XRPL pivot toward tokenized assets and notes that an institutional research shop (Bitwise) has framed XRP as a way to play the tokenization theme. In his construction, if “trillions of dollars in value” begin settling across XRPL rails, working inventories of XRP for bridging, liquidity and settlement could rise sharply, tightening effective float. Related Reading: XRP Bearish Signal: Whales Offload $486 Million In Asset To illustrate, he offers two analogies. First, the “concert tickets” model: you think there are 100,000 tickets (100B supply), but 50,000 are held by the promoter (escrow) and 30,000 by corporate buyers (whales), leaving only 20,000 for the public; if a million people want in, prices explode. Second, a comparison to Bitcoin’s halving: while XRP has no programmatic halving, he proposes that a sudden adoption wave could function like a de facto halving of available supply—“XRP’s version of a halving could actually be the adoption event.” He also updates the narrative context that long dogged XRP. Once derided for “too much supply,” he argues the script has “totally flipped.” He cites the current cycle’s optics—“XRP is sitting above $3 with a market cap north of around $180 billion”—as evidence that raw supply counts did not cap price as tightly as critics claimed, and as a backdrop for why a scarcity narrative is gaining traction. Still, he declines to publish targets or timelines, repeatedly stressing uncertainty and risk. “I’m not a financial adviser… cryptocurrencies are highly volatile,” he reminds viewers, adding that tokenization could take off “on some other platform,” unfold more slowly than enthusiasts expect, or fail to get to “sudden shock” scale. The verdict he offers is deliberately bound. The theory that “XRP supply could vanish overnight” is imprecise on its face; the ledger will not erase coins. But after examining dashboard methodologies, escrow mechanics and the behavior of large holders, he concludes that the effective float could be meaningfully smaller than headline supply figures, and that a fast-developing tokenization use case could, under the right conditions, stress that float. “Overnight is a dramatic way to put it,” he concedes. “The change could actually be very sudden when it comes.” At press time, XRP traded at $3.0198. Featured image created with DALL.E, chart from TradingView.com
Paylaş
NewsBTC2025/09/18 11:00
US and UK Set to Seal Landmark Crypto Cooperation Deal

US and UK Set to Seal Landmark Crypto Cooperation Deal

The United States and the United Kingdom are preparing to announce a new agreement on digital assets, with a focus on stablecoins, following high-level talks between senior officials and major industry players.
Paylaş
Cryptodaily2025/09/18 00:49
Dogecoin ETF Set to Go Live Today

Dogecoin ETF Set to Go Live Today

The post Dogecoin ETF Set to Go Live Today appeared on BitcoinEthereumNews.com. Altcoins 18 September 2025 | 09:35 The U.S. market is about to see a first-of-its-kind moment in crypto investing. Beginning September 18, investors are expected to be able to buy exchange-traded funds (ETFs) tied directly to XRP and Dogecoin, bringing two of the most recognizable digital assets into mainstream brokerage accounts. The products — the REX-Osprey XRP ETF (XRPR) and REX-Osprey Dogecoin ETF (DOJE) — are being launched through a partnership between REX Shares and Osprey Funds. It marks the first time spot XRP and spot DOGE exposure will be available in ETF form for U.S. traders, a move that analysts describe as historic for the broader digital asset space. Industry voices quickly highlighted the importance of the rollout. ETF Store President Nate Geraci noted that the launch not only introduces the first Dogecoin ETF but also finally delivers spot XRP access for traditional investors. Bloomberg ETF analysts Eric Balchunas and James Seyffart confirmed that trading will begin September 18, following a brief delay from the original timeline. Both ETFs are housed under a single prospectus that also covers planned funds for TRUMP and BONK, though those launches have yet to receive confirmed dates. By wrapping these tokens in an ETF structure, investors will no longer need to navigate crypto exchanges or wallets to gain exposure — instead, access will be as simple as purchasing shares through a brokerage account. The arrival of these products could set the stage for a wave of new altcoin-based ETFs, expanding the landscape beyond Bitcoin and Ethereum and opening the door to mainstream adoption of other popular tokens. Author Alexander Zdravkov is a person who always looks for the logic behind things. He is fluent in German and has more than 3 years of experience in the crypto space, where he skillfully identifies new…
Paylaş
BitcoinEthereumNews2025/09/18 14:38